⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 22, 2024Future OncologyOpen Access

Patient preferences for chronic lymphocytic leukemia treatments: a discrete-choice experiment

A. G. RAVELO Kelley Myers Robyn Brumble Cooper Bussberg Brian Koffman Beenish S. Manzoor Juliana M.L. Biondo Carol Mansfield

View Full Paper

Ask AI

Bookmark

Share

Abstract

Patient preferences for the features of targeted chronic lymphocytic leukemia (CLL) therapies may differ.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

RAVELO et al. (2024) studied this question.

synapsesocial.com/papers/68e68e7db6db643587615c1f https://doi.org/10.1080/14796694.2024.2348440

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Elicitation of societal preferences for chronic lymphocytic leukemia’s treatments: a discrete choice experiment2024 · 2 citations
2Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference studyOriginal Research · 2026
3Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia: A Multinational Discrete Choice ExperimentNarrative Review · 2026
4Evaluating patient preferences for chronic lymphocytic leukemia (CLL) in Korea: A discrete choice experiment2025
5Patient Preferences for Treatment in Relapsed/Refractory Acute Leukemia in the United Kingdom: A Discrete Choice Experiment2024 · 5 citations